2 FTSE stocks I’d be willing to put 100% of my money into for passive income!

If I were only able to buy a limited number of stocks to generate a passive income stream, I’d definitely consider these two picks.

| More on:

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Building a passive income stream from dividend paying stocks is a tried and tested method many seasoned investors undertake.

The general rule of thumb is that diversification is a must to ensure maximum returns, as well as protection for my portfolio.

However, let’s say for the purposes of this article I had to choose just two stocks to build my additional income stream. I’d choose National Grid (LSE: NG.) and GSK (LSE: GSK) shares to buy.

Here’s why!

National Grid

The owner and operator of the gas and electricity transmission system in the UK is a rock-solid stock, in my view.

A big part of this is due to its monopoly on operations in the UK and its defensive traits. It’s the only provider of its kind, so competition isn’t an issue.

From a defensive view, energy is a basic requirement for all. We all need gas and electricity, no matter the economic outlook.

Both of these aspects allow revenues to remain stable, and therefore provide consistent investor rewards.

From a fundamentals perspective, a dividend yield of over 5% is attractive. This is higher than the FTSE 100 average of 3.9%. However, it is worth remembering that dividends are never guaranteed.

Moving on, the shares look good value for money to me on a price-to-earnings ratio of 15. This is slightly above average because of the level of security the stock offers, in my view.

Despite my bullish stance on the stock, there are risks to bear in mind that could hurt payouts. To start with, it has a fair bit of debt on its balance sheet, over £45bn at present. Paying this down could hurt payout levels.

In addition to this, the investment required to maintain a large, vital piece of infrastructure in the country could be hugely expensive. This investment could also impact shareholder value and dividends.

Overall, a defensive stock with a monopoly, as well as an attractive return level and valuation help my investment case.


As one of the world’s largest pharmaceutical research businesses, GSK possesses an enviable track record of performance. Furthermore, its brand power and market position are also major draws.

From a risk perspective, pharma stocks are prone to issues such as R&D complications. There is every chance that product launches, trials, and other issues could hurt GSK’s investment viability if they fail. Plus, these same issues could dent performance and returns.

In addition to this, actually creating a treatment or drug can cost millions, if not more just to bring to market. Lots of investment is required, therefore spending lots in this stage and a poor return on investment in the form of sales could hurt dividends.

However, GSK’s current burgeoning pipeline and experience offer me solace. Plus, the shares look good value for money on a price-to-earnings ratio of just 10. Plus, a forward dividend yield of just over 4% is attractive.

Finally, GSK does have a sense of defensive ability too, if you ask me. This is because demand for healthcare, pharma products and treatments are basic requirements. Plus, as the global population continues to increase, GSK could capitalise.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Photo of a man going through financial problems
Investing Articles

Down 15% in a week! What’s gone wrong with the National Grid share price?

The National Grid share price isn't supposed to crash but now it has. Harvey Jones is wondering whether to take…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

Taylor Wimpey just paid me £158.78. I’m aiming to turn that into a £100k yearly second income

Harvey Jones says small, regular dividend payments can turn a few pounds into a mighty second income, if he gives…

Read more »

A pastel colored growing graph with rising rocket.
Value Shares

These FTSE 250 shares are tipped to rise 14% to 18% in the next year!

Looking for the best FTSE 250 momentum shares to buy? Here are two that City analysts expect to soar in…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

Lloyds’ share price is up 20% in 3 months! How high can it go?

Lloyds’ share price has ripped higher recently. Here, Edward Sheldon provides his view on the level it could potentially climb…

Read more »

Investing Articles

Why the Rolls-Royce share price could continue to outperform

The Rolls-Royce share price keeps moving forward, but this Fool thinks it's still behind where it ought to be after…

Read more »

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

The City expects explosive growth in earnings from this almost-penny stock

It’s rare to find earnings predictions as robust as those for this not-quite-a-penny stock, so I’d research and consider it…

Read more »

Investing Articles

As earnings rise 600%, is Nvidia still the best AI stock to buy?

With the supply and demand equation still looking strong for Nvidia, is the stock still the best AI opportunity for…

Read more »

Value Shares

Cheap UK stocks are soaring! Here’s 1 to consider buying now

In recent weeks, many UK stocks have surged. Here, Edward Sheldon highlights a blue-chip FTSE 100 share he believes could…

Read more »